Efficient Microscale Basic Reverse Phase Peptide Fractionation for Global and Targeted Proteomics.

about

Efficient Microscale Basic Reverse Phase Peptide Fractionation for Global and Targeted Proteomics.

Item

http://www.wikidata.org/entity/Q39714786

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Efficient Microscale Basic Rev ...... lobal and Targeted Proteomics.

@en

Efficient Microscale Basic Rev ...... lobal and Targeted Proteomics.

@nl

type

Item

label

Efficient Microscale Basic Rev ...... lobal and Targeted Proteomics.

@en

Efficient Microscale Basic Rev ...... lobal and Targeted Proteomics.

@nl

prefLabel

Efficient Microscale Basic Rev ...... lobal and Targeted Proteomics.

@en

Efficient Microscale Basic Rev ...... lobal and Targeted Proteomics.

@nl

P1476

Efficient Microscale Basic Rev ...... lobal and Targeted Proteomics.

@en

P2093

Daniel C Liebler

http://www.w3.org/2001/XMLSchema#string

Hye-Jung Kim

http://www.w3.org/2001/XMLSchema#string

Hyoung-Joo Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips

Skyline: an open source document editor for creating and analyzing targeted proteomics experiments

Comparative shotgun proteomics using spectral count data and quasi-likelihood modeling.

Identifying proteomic LC-MS/MS data sets with Bumbershoot and IDPicker

Targeted quantitation of proteins by mass spectrometry.

Isobaric labeling-based relative quantification in shotgun proteomics.

Methods for peptide and protein quantitation by liquid chromatography-multiple reaction monitoring mass spectrometry.

Proteomic challenges: sample preparation techniques for microgram-quantity protein analysis from biological samples.

Quantitative Profiling of Protein Tyrosine Kinases in Human Cancer Cell Lines by Multiplexed Parallel Reaction Monitoring Assays

Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1.

P304

2346-2354

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACS.JPROTEOME.6B00102

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27255222

http://www.w3.org/2001/XMLSchema#string

P932

5785084

http://www.w3.org/2001/XMLSchema#string